| 000 | 05758nam a22010577a 4500 | ||
|---|---|---|---|
| 008 | 240807s20242024 xxu||||| |||| 00| 0 eng d | ||
| 022 | _a1941-7640 | ||
| 040 | _aOvid MEDLINE(R) | ||
| 099 | _a38853766 | ||
| 245 | _aBioprosthetic Aortic Valve Thrombosis: Definitions, Clinical Impact, and Management: A State-of-the-Art Review. [Review] | ||
| 251 | _aCirculation: Cardiovascular Interventions. 17(7):e014143, 2024 Jul. | ||
| 252 | _aCirc., Cardiovasc. interv.. 17(7):e014143, 2024 Jul. | ||
| 253 | _aCirculation. Cardiovascular interventions | ||
| 260 | _c2024 | ||
| 260 | _fFY2024 | ||
| 260 | _p2024 Jul | ||
| 265 | _sppublish | ||
| 265 | _tMEDLINE | ||
| 266 | _d2024-08-07 | ||
| 266 | _z2024/06/10 05:12 | ||
| 501 | _aAvailable online from MWHC library: 2008 - present | ||
| 520 | _aBioprosthetic aortic valve thrombosis is frequently detected after transcatheter and surgical aortic valve replacement due to advances in cardiac computed tomography angiography technology and standardized surveillance protocols in low-surgical-risk transcatheter aortic valve replacement trials. However, evidence is limited concerning whether subclinical leaflet thrombosis leads to clinical adverse events or premature structural valve deterioration. Furthermore, there may be net harm in the form of bleeding from aggressive antithrombotic treatment in patients with subclinical leaflet thrombosis. This review will discuss the incidence, mechanisms, diagnosis, and optimal management of bioprosthetic aortic valve thrombosis after transcatheter aortic valve replacement and bioprosthetic surgical aortic valve replacement. | ||
| 546 | _aEnglish | ||
| 650 | _a*Aortic Valve | ||
| 650 | _a*Bioprosthesis | ||
| 650 | _a*Fibrinolytic Agents | ||
| 650 | _a*Heart Valve Prosthesis | ||
| 650 | _a*Heart Valve Prosthesis Implantation | ||
| 650 | _a*Prosthesis Design | ||
| 650 | _a*Thrombosis | ||
| 650 | _a*Transcatheter Aortic Valve Replacement | ||
| 650 | _aAnticoagulants/ad [Administration & Dosage] | ||
| 650 | _aAnticoagulants/ae [Adverse Effects] | ||
| 650 | _aAnticoagulants/tu [Therapeutic Use] | ||
| 650 | _aAortic Valve/dg [Diagnostic Imaging] | ||
| 650 | _aAortic Valve/pp [Physiopathology] | ||
| 650 | _aAortic Valve/su [Surgery] | ||
| 650 | _aBioprosthesis/ae [Adverse Effects] | ||
| 650 | _aFibrinolytic Agents/ad [Administration & Dosage] | ||
| 650 | _aFibrinolytic Agents/ae [Adverse Effects] | ||
| 650 | _aHeart Valve Prosthesis Implantation/ae [Adverse Effects] | ||
| 650 | _aHeart Valve Prosthesis Implantation/is [Instrumentation] | ||
| 650 | _aHeart Valve Prosthesis/ae [Adverse Effects] | ||
| 650 | _aHumans | ||
| 650 | _aIncidence | ||
| 650 | _aPredictive Value of Tests | ||
| 650 | _aRisk Assessment | ||
| 650 | _aRisk Factors | ||
| 650 | _aThrombosis/dg [Diagnostic Imaging] | ||
| 650 | _aThrombosis/et [Etiology] | ||
| 650 | _aThrombosis/th [Therapy] | ||
| 650 | _aTranscatheter Aortic Valve Replacement/ae [Adverse Effects] | ||
| 650 | _aTranscatheter Aortic Valve Replacement/is [Instrumentation] | ||
| 650 | _aTreatment Outcome | ||
| 650 | _zAutomated | ||
| 651 | _aMedStar Heart & Vascular Institute | ||
| 651 | _aMedStar Washington Hospital Center | ||
| 656 | _aAdvanced Cardiac Catheterization Research Fellowship | ||
| 656 | _aInterventional Cardiology Fellowship | ||
| 657 | _aJournal Article | ||
| 657 | _aReview | ||
| 700 |
_aAbusnina, Waiel _bMWHC _cAdvanced Cardiac Catheterization Research Fellowship _dMBBCh |
||
| 700 |
_aAl-Qaraghuli, Abdullah K _bMHVI |
||
| 700 |
_aAladin, Amer _bMWHC _cInterventional Cardiology Fellowship _dMBChB |
||
| 700 |
_aBanerjee, Avantika _bMHVI |
||
| 700 |
_aBen-Dor, Itsik _bMHVI |
||
| 700 |
_aBraun, Ryan _bMHVI |
||
| 700 |
_aCase, Brian C _bMHVI |
||
| 700 |
_aChaturvedi, Abhishek _bMWHC _cAdvanced Cardiac Catheterization Research Fellowship _dMBBS |
||
| 700 |
_aChitturi, Kalyan _bMWHC _cAdvanced Cardiac Catheterization Research Fellowship _dDO |
||
| 700 |
_aHaberman, Dan _bMWHC _cInterventional Cardiology Fellowship _dMD |
||
| 700 |
_aLupu, Lior _bMWHC _cInterventional Cardiology Fellowship _dMBA, MD |
||
| 700 |
_aMerdler, Ilan _bMHVI |
||
| 700 |
_aReddy, Pavan _bMWHC _cAdvanced Cardiac Catheterization Research Fellowship _dMD |
||
| 700 |
_aRodriguez-Weisson, Fernando J _bMHVI |
||
| 700 |
_aRogers, Toby _bMHVI |
||
| 700 |
_aSatler, Lowell F _bMHVI |
||
| 700 |
_aWaksman, Ron _bMHVI |
||
| 700 |
_aWermers, Jason P _bMHVI |
||
| 790 | _aChitturi KR, Aladin AI, Braun R, Al-Qaraghuli AK, Banerjee A, Reddy P, Merdler I, Chaturvedi A, Abusnina W, Haberman D, Lupu L, Rodriguez-Weisson FJ, Case BC, Wermers JP, Ben-Dor I, Satler LF, Waksman R, Rogers T | ||
| 856 |
_uhttps://dx.doi.org/10.1161/CIRCINTERVENTIONS.123.014143 _zhttps://dx.doi.org/10.1161/CIRCINTERVENTIONS.123.014143 |
||
| 858 |
_yAladin, Amer I _uhttps://orcid.org/0000-0003-0892-9319 _zhttps://orcid.org/0000-0003-0892-9319 |
||
| 858 |
_yCase, Brian C _uhttps://orcid.org/0000-0001-5355-9594 _zhttps://orcid.org/0000-0001-5355-9594 |
||
| 858 |
_yChaturvedi, Abhishek _uhttps://orcid.org/0000-0003-0241-2845 _zhttps://orcid.org/0000-0003-0241-2845 |
||
| 858 |
_yChitturi, Kalyan R _uhttps://orcid.org/0000-0003-0602-2684 _zhttps://orcid.org/0000-0003-0602-2684 |
||
| 858 |
_yReddy, Pavan _uhttps://orcid.org/0000-0001-8913-7430 _zhttps://orcid.org/0000-0001-8913-7430 |
||
| 858 |
_yRogers, Toby _uhttps://orcid.org/0000-0002-6043-3137 _zhttps://orcid.org/0000-0002-6043-3137 |
||
| 858 |
_yWaksman, Ron _uhttps://orcid.org/0000-0002-4063-9226 _zhttps://orcid.org/0000-0002-4063-9226 |
||
| 858 |
_yWermers, Jason P _uhttps://orcid.org/0000-0003-1983-9546 _zhttps://orcid.org/0000-0003-1983-9546 |
||
| 942 |
_cART _dArticle |
||
| 999 |
_c14535 _d14535 |
||